Silicone-free glass pre-filled syringe system for Biological Drugs.
Silicone-free glass pre-filled syringe system for Biological Drugs.
批准号:
7669963
负责人:
LaToya Jones Braun
金额:
$22.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-15 至 2011-03-14
关键词:
AddressAdhesionsAffectAutomobile DrivingBiochemistryBiologicalCellsChemistryChronicCircular DichroismCollaborationsColoradoDevelopmentDevicesDiabetes MellitusDifferential Scanning CalorimetryDoseDrug ContaminationDrug FormulationsDrug IndustryDrug PackagingDrug-sensitiveEnsureEnvironmentFluorescence SpectroscopyGenerationsGlassGrantHormonalHumanImmunoglobulin GIndustryInjection of therapeutic agentInsulinLifeLiquid substanceLubricantsLubricationMarketingMeasuresMedical DeviceMonitorMonoclonal AntibodiesOperative Surgical ProceduresOxygenParticulateParticulate MatterPatientsPeptidesPerformancePharmaceutical PreparationsPharmacologic SubstancePhasePlasmaPlasticsPrecipitationProceduresProcessPropertyProteinsProtocols documentationResearchResearch DesignRheumatoid ArthritisSelf-control as a personality traitSerum AlbuminSilicone OilsSiliconesSmall Business Innovation Research GrantSolutionsSpectrum AnalysisSurfaceSyringesSystemTechnologyTestingThermodynamicsUniversitiesVaccinesVial deviceWaterbasebiological systemscrosslinkdosageexperiencemigrationperfluoropolyetherprotein aggregateprotein aggregationpublic health relevancestability testingwater vapor
中文摘要
描述(由申请人提供):在医疗器械行业中,硅油是一种普遍存在的润滑剂-用于组件的制造和组装,也可作为器械正常运行的终端润滑剂。对于预充式注射器,当硅油的微滴迁移到药物介质中并作为包装药物的污染物和可能的反应物时,就会出现问题。在生物药物的情况下,这种硅油污染涉及蛋白质构象变化和聚集。用于预充式应用的玻璃注射器主要使用硅油作为润滑剂。无硅油玻璃预充式器械是非常理想的,但在被接受之前,需要进行各种药物成分的稳定性测试以及长期储存后的颗粒和力测试。我们建议开发具有基于全氟聚醚化学的TriboGlide(r)无硅润滑系统的玻璃预充式注射器。提出了加速储存条件对松脱力和挤出注射器力的影响沿着,以及标准硅油润滑和TriboGlide(r)无硅胶注射器之间微粒生成的比较。在与科罗拉多丹佛大学的合作中,UCD将TriboGlide(r)注射器与标准硅化注射器作为蛋白质制剂包装装置进行比较。将评估蛋白沉淀(UV/维斯光谱)、可溶性蛋白损失(SE-HPLC)、吸附蛋白对注射器力的影响和注射用水的pH值变化。本研究选择的蛋白质是人血清白蛋白、人IgG、胰岛素和abatecept(布里斯托迈尔斯施贵宝公司的单克隆抗体)。在第二阶段,我们建议使用圆二色谱和荧光光谱法评价TriboGlide(r)玻璃注射器对蛋白质二级和三级结构变化的影响。将使用差示扫描量热法检测在注射器中长期储存后蛋白质的热力学稳定性变化。最后,凭借来自UCD的LaToya Jones Braun博士在疫苗方面的丰富经验,我们将评估储存在注射器中的各种疫苗制剂的稳定性。医疗器械和制药行业长期以来一直希望有一种不影响溶液中包装药物稳定性的完全无硅系统。如果成功,TriboGlide将成为第一个通用的无硅玻璃预充式注射器系统,其应用范围将扩展到其他医疗器械。公共卫生相关性:病人控制的自我治疗是一个很大的驱动因素,药物包装在单剂量预充式注射器格式治疗慢性疾病,如类风湿性关节炎和糖尿病。其他优点包括减少错误、易于使用、精确剂量、在多剂量疫苗的情况下消除防腐剂,以及最重要的是减少包装在小瓶中所需的药物的过量填充。作为润滑剂的硅油可使注射器易于操作,但会污染制剂并与敏感药物发生不良反应。申报的TriboGlide系统将是第一个用于玻璃预充式注射器的无硅油系统,可克服润滑剂迁移和药物污染问题。
英文摘要
DESCRIPTION (provided by applicant): In the medical device industry, silicone oil is a ubiquitous lubricant - used in the manufacture and assembly of components and also as the terminal lubricant for proper device operation. For prefilled syringes, the problem arises when micro-droplets of silicone oil migrate into the drug medium and act as a contaminant and possible reactant for the packaged drug. In the case of biological drugs, such silicone oil contamination has been implicated in protein conformational changes and aggregation. Glass syringes for prefilled applications predominantly use silicone oil as a lubricant. A silicone oil-free glass prefilled device is highly desired, but before it would be accepted, stability testing with various pharmaceutical ingredients as well as particulate and force testing after extended storage is required. We propose the development of glass prefilled syringes with the TriboGlide(r) silicone-free lubrication system based on perfluoropolyether chemistry. The effect of accelerated storage conditions on break-loose and extrusion syringe forces along with comparison of the particulate generation between standard silicone oil lubricated and TriboGlide(r) silicone-free syringes is proposed. In collaboration with the University of Colorado Denver, UCD, TriboGlide(r) syringes will be compared to standard siliconized syringes as devices for packaging of protein formulations. Protein precipitation (UV/Vis spectroscopy), loss of soluble protein (SE-HPLC), influence of adsorbed protein on syringe forces, and pH shifts in water for injection will be assessed. The proteins selected for this study are human serum albumin, human IgG, insulin, and abatecept (monoclonal antibody by Bristol Myers Squibb). In phase II, we propose to evaluate the TriboGlide(r) glass syringes for effects on secondary and tertiary structural changes of the proteins, using circular dichroism and fluorescence spectroscopy. Differential scanning calorimetry will be used to detect changes in the thermodynamic stability of the proteins after extended storage in the syringes. Finally, with the extensive experience in vaccines brought by Dr. LaToya Jones Braun from UCD, we will evaluate the stability of various vaccine formulations stored in the syringes. The medical device and pharmaceutical industries have long desired a completely silicone-free system that does not affect the stability of the packaged drug in solution. If successful, TriboGlide will be the first universal silicone-free system for glass prefilled syringes with applications extending to other medical devices. PUBLIC HEALTH RELEVANCE: Patient controlled self-therapy is a big driving factor for drugs packaged in single-dose prefilled syringe formats for treatment of chronic ailments such as rheumatoid arthritis and diabetes. Other advantages include reduced errors, ease of use, accurate dosage, elimination of preservatives in case of multi-dose vaccines and above all reduced overfill of drugs that are required for packaging in vials. Silicone oil, which serves as a lubricant for easy operation of the syringe, can contaminate the drug product and adversely interact with the sensitive drugs. The proposed TriboGlide system will be the first silicone oil-free system for glass prefilled syringes that overcomes the problems of lubricant migration and drug contamination.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Silicone-free glass pre-filled syringe system for Biological Drugs.
-
批准号:8530266
-
项目类别:
-
资助金额:$76.46万
-
财政年份:2009
-
负责人:LaToya Jones Braun
-
依托单位:
Silicone-free glass pre-filled syringe system for Biological Drugs.
-
批准号:8393251
-
项目类别:
-
资助金额:$69.76万
-
财政年份:2009
-
负责人:LaToya Jones Braun
-
依托单位:
海外基金